Masahiro Asakage
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Pathology and Forensic Medicine top 10%
- Oncology
- Co-authors
- Hirokazu NagawaNelson H. TsunoYurai OkajiKoki TakahashiJoji KitayamaKazushige KawaiKentaro YazawaHiroharu Yamashita
- Topics
- Angiogenesis and VEGF in Cancer (6 papers)Inflammatory mediators and NSAID effects (5 papers)Tea Polyphenols and Effects (4 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Masahiro Asakage
25 papers receiving 939 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 293
- Pulmonary and Respiratory Medicine 239
- Surgery 222
- Pathology and Forensic Medicine 167
- Oncology 166
Countries citing papers authored by Masahiro Asakage
This map shows the geographic impact of Masahiro Asakage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Asakage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Asakage more than expected).
Fields of papers citing papers by Masahiro Asakage
This network shows the impact of papers produced by Masahiro Asakage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Asakage. The network helps show where Masahiro Asakage may publish in the future.
Co-authorship network of co-authors of Masahiro Asakage
This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Asakage. A scholar is included among the top collaborators of Masahiro Asakage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Asakage. Masahiro Asakage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 75 | |
| 2 | [The chemotherapy with mFOLFOX6 for advanced colon cancer was effective for gastric cancer - a case report]. | 1 |
| 3 | 52 | |
| 4 | 58 | |
| 5 | 56 | |
| 6 | 7 | |
| 7 | Zoledronic acid inhibits gastric cancer cells by induction of apoptosis | 2 |
| 8 | 6 | |
| 9 | 55 | |
| 10 | 50 | |
| 11 | 22 | |
| 12 | 15 | |
| 13 | 13 | |
| 14 | 47 | |
| 15 | 17 | |
| 16 | 8 | |
| 17 | 36 | |
| 18 | 80 | |
| 19 | 53 | |
| 20 | 117 |
About Masahiro Asakage
Masahiro Asakage is a scholar working on Applied Microbiology and Biotechnology, Immunology and Allergy and Gastroenterology, having authored 25 papers that have together received 959 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Tea Polyphenols and Effects (4 papers). The work is most often cited by research in Gastroenterology (106 citations), Biochemistry (78 citations) and Biological Psychiatry (29 citations). Masahiro Asakage has collaborated with scholars based in Japan and United States. Frequent co-authors include Hirokazu Nagawa, Nelson H. Tsuno, Yurai Okaji, Koki Takahashi, Joji Kitayama, Kazushige Kawai, Kentaro Yazawa, Joji Kitayama, Hiroharu Yamashita and Jun Yamada. Their work appears in journals such as Cancer Research, Journal of Allergy and Clinical Immunology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.